Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Gottlieb

Showing results (301-310 of 609) with videos related to

Pageof 61
Sort By:
Journal of Dermatological Science|March 24, 2016
Methotrexate improves pro- and anti-atherogenic genomic expression in psoriatic skinAri M Goldminz, Mayte Suárez-Fariñas, Andrew C Wang, et al.
The American Journal of Dermatopathology|October 1, 1984
Demonstration in situ of subsets of T-lymphocytes in sarcoidosisR L Modlin, F M Hofman, O P Sharma, et al.
The Journal of Experimental Medicine|October 1, 1986
Expression of HLA-DR molecules by keratinocytes, and presence of Langerhans cells in the dermal infiltrate of active psoriatic plaquesA B Gottlieb, B Lifshitz, S M Fu, et al.
The Journal of Dermatological Treatment|February 10, 2006
Clinical response in psoriasis patients discontinued from and then reinitiated on etanercept therapyKenneth B Gordon, Alice B Gottlieb, Craig L Leonardi, et al.
Journal of the American Academy of Dermatology|July 1, 1985
A membrane protein preferentially expressed by a subpopulation of immature lymphoid cells, epidermal basal keratinocytes, and other epithelial cellsA B Gottlieb, L Mayer, F Bonetti, et al.
Journal of Drugs in Dermatology : JDD|October 15, 2016
Secukinumab Self-Administration by Prefilled Syringe Maintains Reduction of Plaque Psoriasis Severity Over 52 Weeks: Results of the FEATURE TrialAlice B Gottlieb, Andrew Blauvelt, Jörg C Prinz, et al.
The Journal of Dermatological Treatment|April 18, 2020
Indirect comparisons of ixekizumab versus three interleukin-23 p19 inhibitors in patients with moderate-to-severe plaque psoriasis - efficacy findings up to week 12Alice B Gottlieb, Daniel Saure, Stefan Wilhelm, et al.
Breast Cancer Research and Treatment|January 5, 2002
The polymorphic CAG repeat of the androgen receptor gene: a potential role in breast cancer in women over 40Y A Elhaji, B Gottlieb, R Lumbroso, et al.
Current Medical Research and Opinion|April 19, 2008
An open-label, single-arm pilot study in patients with severe plaque-type psoriasis treated with an oral anti-inflammatory agent, apremilastA B Gottlieb, B Strober, J G Krueger, et al.
International Journal of Women'S Dermatology|November 6, 2023
Ethiopian residents' attitudes toward dermatology research: a survey studyRishab R Revankar, Heli A Patel, Joo Yeon Shin, et al.
Pageof 61

Showing results (301-310 of 609) with videos related to

Sort By:
Pageof 61
Journal of Dermatological Science|March 24, 2016
Methotrexate improves pro- and anti-atherogenic genomic expression in psoriatic skinAri M Goldminz, Mayte Suárez-Fariñas, Andrew C Wang, et al.
The American Journal of Dermatopathology|October 1, 1984
Demonstration in situ of subsets of T-lymphocytes in sarcoidosisR L Modlin, F M Hofman, O P Sharma, et al.
The Journal of Experimental Medicine|October 1, 1986
Expression of HLA-DR molecules by keratinocytes, and presence of Langerhans cells in the dermal infiltrate of active psoriatic plaquesA B Gottlieb, B Lifshitz, S M Fu, et al.
The Journal of Dermatological Treatment|February 10, 2006
Clinical response in psoriasis patients discontinued from and then reinitiated on etanercept therapyKenneth B Gordon, Alice B Gottlieb, Craig L Leonardi, et al.
Journal of the American Academy of Dermatology|July 1, 1985
A membrane protein preferentially expressed by a subpopulation of immature lymphoid cells, epidermal basal keratinocytes, and other epithelial cellsA B Gottlieb, L Mayer, F Bonetti, et al.
Journal of Drugs in Dermatology : JDD|October 15, 2016
Secukinumab Self-Administration by Prefilled Syringe Maintains Reduction of Plaque Psoriasis Severity Over 52 Weeks: Results of the FEATURE TrialAlice B Gottlieb, Andrew Blauvelt, Jörg C Prinz, et al.
The Journal of Dermatological Treatment|April 18, 2020
Indirect comparisons of ixekizumab versus three interleukin-23 p19 inhibitors in patients with moderate-to-severe plaque psoriasis - efficacy findings up to week 12Alice B Gottlieb, Daniel Saure, Stefan Wilhelm, et al.
Breast Cancer Research and Treatment|January 5, 2002
The polymorphic CAG repeat of the androgen receptor gene: a potential role in breast cancer in women over 40Y A Elhaji, B Gottlieb, R Lumbroso, et al.
Current Medical Research and Opinion|April 19, 2008
An open-label, single-arm pilot study in patients with severe plaque-type psoriasis treated with an oral anti-inflammatory agent, apremilastA B Gottlieb, B Strober, J G Krueger, et al.
International Journal of Women'S Dermatology|November 6, 2023
Ethiopian residents' attitudes toward dermatology research: a survey studyRishab R Revankar, Heli A Patel, Joo Yeon Shin, et al.
Pageof 61